Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Snap One price target lowered to $19 from $24 at UBS » 07:09
05/18/22
05/18
07:09
05/18/22
07:09
SNPO

Snap One

$11.32 /

+0.04 (+0.35%)

UBS analyst Chris Snyder…

UBS analyst Chris Snyder lowered the firm's price target on Snap One to $19 from $24 but keeps a Buy rating on the shares. The company reported a "healthy" Q1 earnings beat and a slight Q2 guidance raise, but his price target cut reflects the valuations among its peer group having "de-rated considerably", the analyst tells investors in a research note. Snyder adds that he continues to see a healthy growth outlook for Snap One behind elevated backlogs and secular tailwind for Smart Home and Building penetration,

ShowHide Related Items >><<
SNPO Snap One
$11.32 /

+0.04 (+0.35%)

SNPO Snap One
$11.32 /

+0.04 (+0.35%)

05/16/22 Truist
Snap One price target lowered to $18 from $21 at Truist
03/25/22 Truist
Snap One price target lowered to $21 from $25 at Truist
03/23/22 JPMorgan
Snap One price target lowered to $24 from $25 at JPMorgan
12/09/21 Morgan Stanley
Snap One downgraded to Equal Weight at Morgan Stanley following 'too fast' rally
SNPO Snap One
$11.32 /

+0.04 (+0.35%)

  • 28
    Jul
SNPO Snap One
$11.32 /

+0.04 (+0.35%)

Recommendations
Snap One price target lowered to $18 from $21 at Truist » 09:31
05/16/22
05/16
09:31
05/16/22
09:31
SNPO

Snap One

$12.53 /

+1.23 (+10.88%)

Truist analyst Keith…

Truist analyst Keith Hughes lowered the firm's price target on Snap One to $18 from $21 to reflect the impact of higher interest rates but keeps a Buy rating on the shares. The company's Q1 results were above expectations with "outstanding" organic growth and a "particularly solid" unit gain despite supply chain headwinds, the analyst tells investors in a research note. Hughes adds however that while Snap One margins disappointed as cost was not fully covered, another increase in selling prices in June "should make them whole".

ShowHide Related Items >><<
SNPO Snap One
$12.53 /

+1.23 (+10.88%)

SNPO Snap One
$12.53 /

+1.23 (+10.88%)

03/25/22 Truist
Snap One price target lowered to $21 from $25 at Truist
03/23/22 JPMorgan
Snap One price target lowered to $24 from $25 at JPMorgan
12/09/21 Morgan Stanley
Snap One downgraded to Equal Weight at Morgan Stanley following 'too fast' rally
12/09/21 Morgan Stanley
Snap One downgraded to Equal Weight from Overweight at Morgan Stanley
SNPO Snap One
$12.53 /

+1.23 (+10.88%)

  • 28
    Jul
SNPO Snap One
$12.53 /

+1.23 (+10.88%)

Earnings
Snap One raises FY22 revenue view $1.16B-$1.18B from $1.14B-$1.17B » 16:24
05/12/22
05/12
16:24
05/12/22
16:24
SNPO

Snap One

$11.33 /

+1.31 (+13.07%)

FY22 revenue consensus…

FY22 revenue consensus $1.15B. "Demand for our products and services remains high," Heyman continued. "Despite uncertainty in the macro environment, we have strong conviction in both the short- and long-term growth outlook for our business. Our fiscal 2022 revised guidance considers our fiscal first quarter performance, our most recent price adjustment, effective June 6, 2022, and our anticipation of continued supply chain challenges and uncertainty. Taking these factors into consideration, we expect net sales in the fiscal year ending December 30, 2022 to range between $1.16 billion and $1.18 billion, which would represent an increase of 15% to 17% compared to the prior fiscal year on an as-reported basis, and 17% to 19% after adjusting fiscal 2021 to remove the impact of a 53rd week. This represents an increase of $20 million and $10 million to the low and high end, respectively, of our initial guidance range communicated in March in conjunction with our fiscal 2021 earnings. For fiscal 2022, we now expect adjusted EBITDA to range between $116 million and $121 million, which would represent an increase of 5% to 9% compared to the prior fiscal year on an as-reported basis. Presenting 2021 on a 52-week adjusted basis and annualizing for a full year of public company costs, our 2022 adjusted EBITDA guidance would represent a year-over-year increase of 10% to 15%. This adjusted EBITDA guidance represents an increase of $2 million and $1 million to the low and high end, respectively, of our initial guidance range communicated in March in conjunction with our fiscal 2021 earnings. Overall, we are committed to revolutionizing smart living and helping lead overall industry progress. We remain focused on delivering strong growth and margin expansion over the long-term and reinvesting in the success of Snap One."

ShowHide Related Items >><<
SNPO Snap One
$11.33 /

+1.31 (+13.07%)

SNPO Snap One
$11.33 /

+1.31 (+13.07%)

03/25/22 Truist
Snap One price target lowered to $21 from $25 at Truist
03/23/22 JPMorgan
Snap One price target lowered to $24 from $25 at JPMorgan
12/09/21 Morgan Stanley
Snap One downgraded to Equal Weight at Morgan Stanley following 'too fast' rally
12/09/21 Morgan Stanley
Snap One downgraded to Equal Weight from Overweight at Morgan Stanley
SNPO Snap One
$11.33 /

+1.31 (+13.07%)

  • 28
    Jul
SNPO Snap One
$11.33 /

+1.31 (+13.07%)

Earnings
Snap One reports Q1 EPS (3c), consensus 9c » 16:21
05/12/22
05/12
16:21
05/12/22
16:21
SNPO

Snap One

$11.33 /

+1.31 (+13.07%)

Reports Q1 revenue…

Reports Q1 revenue $277.4M, consensus $252.19M. "Robust, secular demand for smart living experiences continues to propel our business forward as our team delivered yet another strong performance in the first quarter," said Snap One CEO John Heyman. "While market pressures and supply chain challenges from the last few quarters have persisted, we are pushing forward with our strategic objectives to position Snap One and our integrators to capitalize on the long-term market opportunity. So far this year, we've expanded our international presence through our acquisition of Staub Electronics, opened an additional local branch domestically, improved our technology and service offerings through several new product releases, and delivered a unified, award-winning loyalty program for our Partners. Financially, our team's commitment to our Partners positioned us to serve strong integrator demand and deliver $277.4 million in net sales in the first quarter, representing 25.8% year-over-year growth on an as-reported basis, with a net loss of $2.3 million and adjusted EBITDA of $23.6 million. While we expect supply chain challenges to remain for the foreseeable future, we continue to observe favorable demand trends and believe we are well positioned to build on our established market leadership position."

ShowHide Related Items >><<
SNPO Snap One
$11.33 /

+1.31 (+13.07%)

SNPO Snap One
$11.33 /

+1.31 (+13.07%)

03/25/22 Truist
Snap One price target lowered to $21 from $25 at Truist
03/23/22 JPMorgan
Snap One price target lowered to $24 from $25 at JPMorgan
12/09/21 Morgan Stanley
Snap One downgraded to Equal Weight at Morgan Stanley following 'too fast' rally
12/09/21 Morgan Stanley
Snap One downgraded to Equal Weight from Overweight at Morgan Stanley
SNPO Snap One
$11.33 /

+1.31 (+13.07%)

  • 28
    Jul
SNPO Snap One
$11.33 /

+1.31 (+13.07%)

Over a month ago
Conference/Events
Snap One management to meet virtually with Truist » 04:55
03/31/22
03/31
04:55
03/31/22
04:55
SNPO

Snap One

$14.75 /

-0.51 (-3.34%)

Virtual Meeting to be…

Virtual Meeting to be held on March 31 hosted by Truist.

ShowHide Related Items >><<
SNPO Snap One
$14.75 /

-0.51 (-3.34%)

SNPO Snap One
$14.75 /

-0.51 (-3.34%)

03/25/22 Truist
Snap One price target lowered to $21 from $25 at Truist
03/23/22 JPMorgan
Snap One price target lowered to $24 from $25 at JPMorgan
12/09/21 Morgan Stanley
Snap One downgraded to Equal Weight at Morgan Stanley following 'too fast' rally
12/09/21 Morgan Stanley
Snap One downgraded to Equal Weight from Overweight at Morgan Stanley
SNPO Snap One
$14.75 /

-0.51 (-3.34%)

  • 28
    Jul
SNPO Snap One
$14.75 /

-0.51 (-3.34%)

SNPO Snap One
$14.75 /

-0.51 (-3.34%)

Recommendations
Snap One price target lowered to $21 from $25 at Truist » 07:23
03/25/22
03/25
07:23
03/25/22
07:23
SNPO

Snap One

$15.26 /

-1.34 (-8.07%)

Truist analyst Keith…

Truist analyst Keith Hughes lowered the firm's price target on Snap One to $21 from $25 and keeps a Buy rating on the shares. The "substantial" decline in the stock since its Q4 earnings beat reflects the pessimism surrounding building products names more so than Snap One performance, the analyst tells investors in a research note. Hughes adds that he remains constructive overall on the longer-term demand outlook for high-end home automation.

ShowHide Related Items >><<
SNPO Snap One
$15.26 /

-1.34 (-8.07%)

SNPO Snap One
$15.26 /

-1.34 (-8.07%)

03/23/22 JPMorgan
Snap One price target lowered to $24 from $25 at JPMorgan
12/09/21 Morgan Stanley
Snap One downgraded to Equal Weight at Morgan Stanley following 'too fast' rally
12/09/21 Morgan Stanley
Snap One downgraded to Equal Weight from Overweight at Morgan Stanley
09/30/21 Imperial Capital
Snap One initiated with an Outperform at Imperial Capital
SNPO Snap One
$15.26 /

-1.34 (-8.07%)

  • 28
    Jul
SNPO Snap One
$15.26 /

-1.34 (-8.07%)

SNPO Snap One
$15.26 /

-1.34 (-8.07%)

Conference/Events
Snap One management to meet virtually with Truist » 13:01
03/23/22
03/23
13:01
03/23/22
13:01
SNPO

Snap One

$17.50 /

-2.98 (-14.55%)

Virtual Meeting to be…

Virtual Meeting to be held on March 31 hosted by Truist.

ShowHide Related Items >><<
SNPO Snap One
$17.50 /

-2.98 (-14.55%)

SNPO Snap One
$17.50 /

-2.98 (-14.55%)

03/23/22 JPMorgan
Snap One price target lowered to $24 from $25 at JPMorgan
12/09/21 Morgan Stanley
Snap One downgraded to Equal Weight at Morgan Stanley following 'too fast' rally
12/09/21 Morgan Stanley
Snap One downgraded to Equal Weight from Overweight at Morgan Stanley
09/30/21 Imperial Capital
Snap One initiated with an Outperform at Imperial Capital
SNPO Snap One
$17.50 /

-2.98 (-14.55%)

  • 28
    Jul
SNPO Snap One
$17.50 /

-2.98 (-14.55%)

SNPO Snap One
$17.50 /

-2.98 (-14.55%)

Recommendations
Snap One price target lowered to $24 from $25 at JPMorgan » 06:30
03/23/22
03/23
06:30
03/23/22
06:30
SNPO

Snap One

$20.48 /

+1.82 (+9.75%)

JPMorgan analyst Paul…

JPMorgan analyst Paul Chung lowered the firm's price target on Snap One to $24 from $25 and keeps an Overweight rating on the shares following the Q4 results. Strong demand trends, wallet share gains, and expanding integrator networks drove the beat despite lingering supply chain costs, Chung tells investors in a research note. The analyst sees "solid execution" with Snap One exceeding $1B in annual revenues for the first time despite tough macro backdrop.

ShowHide Related Items >><<
SNPO Snap One
$20.48 /

+1.82 (+9.75%)

SNPO Snap One
$20.48 /

+1.82 (+9.75%)

12/09/21 Morgan Stanley
Snap One downgraded to Equal Weight at Morgan Stanley following 'too fast' rally
12/09/21 Morgan Stanley
Snap One downgraded to Equal Weight from Overweight at Morgan Stanley
09/30/21 Imperial Capital
Snap One initiated with an Outperform at Imperial Capital
08/23/21 UBS
Snap One initiated with a Buy at UBS
SNPO Snap One
$20.48 /

+1.82 (+9.75%)

  • 28
    Jul
SNPO Snap One
$20.48 /

+1.82 (+9.75%)

SNPO Snap One
$20.48 /

+1.82 (+9.75%)

On The Fly
Fly Intel: After-Hours Movers » 19:31
03/22/22
03/22
19:31
03/22/22
19:31
XGN

Exagen

$8.25 /

+0.21 (+2.61%)

, MXCT

MaxCyte

$6.90 /

+0.24 (+3.60%)

, ZY

Zymergen

$3.59 /

+0.275 (+8.30%)

, GAN

Gan Limited

$5.45 /

-0.03 (-0.55%)

, POSH

Poshmark

$13.84 /

+1.305 (+10.41%)

, SNPO

Snap One

$20.48 /

+1.82 (+9.75%)

, PAYS

Paysign

$2.50 /

+0.205 (+8.93%)

, WOR

Worthington

$62.16 /

+0.92 (+1.50%)

, ABSI

Absci

$7.48 /

+0.415 (+5.88%)

, ADBE

Adobe

$466.75 /

+13.36 (+2.95%)

, DNAY

Codex DNA

$9.26 /

+0.425 (+4.81%)

, HQY

HealthEquity

$58.53 /

+0.78 (+1.35%)

, PAGS

PagSeguro Digital

$18.60 /

+1.56 (+9.15%)

, AIR

AAR Corp.

$46.83 /

+0.79 (+1.72%)

, LFG

Archaea Energy

$19.55 /

-0.58 (-2.88%)

, E

Eni SpA

$28.86 /

+0.045 (+0.16%)

, PLL

Piedmont Lithium

$75.00 /

+ (+0.00%)

Check out this evening's…

ShowHide Related Items >><<
ZY Zymergen
$3.59 /

+0.275 (+8.30%)

XGN Exagen
$8.25 /

+0.21 (+2.61%)

WOR Worthington
$62.16 /

+0.92 (+1.50%)

SNPO Snap One
$20.48 /

+1.82 (+9.75%)

POSH Poshmark
$13.84 /

+1.305 (+10.41%)

PLL Piedmont Lithium
$75.00 /

+ (+0.00%)

PAYS Paysign
$2.50 /

+0.205 (+8.93%)

PAGS PagSeguro Digital
$18.60 /

+1.56 (+9.15%)

MXCT MaxCyte
$6.90 /

+0.24 (+3.60%)

LFG Archaea Energy
$19.55 /

-0.58 (-2.88%)

HQY HealthEquity
$58.53 /

+0.78 (+1.35%)

GAN Gan Limited
$5.45 /

-0.03 (-0.55%)

E Eni SpA
$28.86 /

+0.045 (+0.16%)

DNAY Codex DNA
$9.26 /

+0.425 (+4.81%)

AIR AAR Corp.
$46.83 /

+0.79 (+1.72%)

ADBE Adobe
$466.75 /

+13.36 (+2.95%)

ABSI Absci
$7.48 /

+0.415 (+5.88%)

XGN Exagen
$8.25 /

+0.21 (+2.61%)

10/14/21 Cowen
Exagen coverage transferred at Cowen
08/10/21 BTIG
Exagen price target lowered to $20 from $23 at BTIG
04/15/21
Fly Intel: Top five analyst initiations
04/15/21 Canaccord
Canaccord starts Exagen at Buy, sees 50% upside potential
MXCT MaxCyte
$6.90 /

+0.24 (+3.60%)

08/24/21
Fly Intel: Top five analyst initiations
08/24/21 Stephens
MaxCyte initiated with an Overweight at Stephens
08/24/21 William Blair
Blair starts MaxCyte at Outperform, sees 'one-of-a-kind opportunity'
08/24/21 William Blair
MaxCyte initiated with an Outperform at William Blair
ZY Zymergen
$3.59 /

+0.275 (+8.30%)

03/02/22 Cowen
Zymergen assumed with a Market Perform at Cowen
01/12/22 HSBC
Zymergen upgraded to Hold from Reduce at HSBC
11/04/21 Goldman Sachs
Zymergen price target lowered to $10.50 from $12 at Goldman Sachs
10/14/21 Cowen
Zymergen coverage transferred at Cowen
GAN Gan Limited
$5.45 /

-0.03 (-0.55%)

03/22/22 Northland
Gan Limited price target lowered to $15 from $30 at Northland
01/04/22 Craig-Hallum
Gan Limited price target lowered to $14 from $18 at Craig-Hallum
10/18/21 B. Riley
Gan agreement with Red Rock overlooked by investors, says B. Riley
09/09/21 Macquarie
Macquarie says own online gaming into 'major catalyst' of NFL kickoff
POSH Poshmark
$13.84 /

+1.305 (+10.41%)

03/17/22 Jefferies
Jefferies starts Poshmark at Hold, has concerns about IDFA impact
03/17/22 Jefferies
Poshmark initiated with a Hold at Jefferies
11/22/21 Guggenheim
Poshmark initiated with a Neutral at Guggenheim
11/16/21 Cowen
Poshmark downgraded to Market Perform from Outperform at Cowen
SNPO Snap One
$20.48 /

+1.82 (+9.75%)

12/09/21 Morgan Stanley
Snap One downgraded to Equal Weight at Morgan Stanley following 'too fast' rally
12/09/21 Morgan Stanley
Snap One downgraded to Equal Weight from Overweight at Morgan Stanley
09/30/21 Imperial Capital
Snap One initiated with an Outperform at Imperial Capital
08/23/21 UBS
Snap One initiated with a Buy at UBS
PAYS Paysign
$2.50 /

+0.205 (+8.93%)

08/20/21 DA Davidson
Paysign upgraded to Buy at DA Davidson on expected accelerated growth
08/19/21 DA Davidson
Paysign upgraded to Buy from Neutral at DA Davidson
08/12/21 Ladenburg
Ladenburg upgrades Paysign to Buy, views pullback as 'attractive opportunity'
08/12/21 Ladenburg
Paysign upgraded to Buy from Neutral at Ladenburg
WOR Worthington
$62.16 /

+0.92 (+1.50%)

08/23/21 Seaport Global
Worthington initiated with a Neutral at Seaport Global
ABSI Absci
$7.48 /

+0.415 (+5.88%)

03/02/22 Cowen
Absci assumed with a Market Perform at Cowen
02/01/22 Berenberg
Absci initiated with a Buy at Berenberg
11/10/21 BofA
Absci downgraded to Underperform from Neutral at BofA
11/10/21 BofA
Absci downgraded to Underperform from Neutral at BofA
ADBE Adobe
$466.75 /

+13.36 (+2.95%)

03/21/22 BMO Capital
Adobe price target lowered to $535 from $650 at BMO Capital
03/21/22 RBC Capital
Adobe price target lowered to $600 from $650 at RBC Capital
03/18/22 Morgan Stanley
Morgan Stanley lays out three 'keys' to change narrative on Adobe
03/18/22 Citi
Adobe price target lowered to $455 from $611 at Citi
DNAY Codex DNA
$9.26 /

+0.425 (+4.81%)

03/02/22 Cowen
Codex DNA assumed with an Outperform at Cowen
12/30/21 KeyBanc
Pfizer deal provides key validation of Codex DNA's technology, says KeyBanc
10/14/21 Cowen
Codex DNA coverage transferred at Cowen
07/13/21 Cowen
Cowen starts 'promising' Codex DNA at Outperform
HQY HealthEquity
$58.53 /

+0.78 (+1.35%)

02/24/22 Deutsche Bank
HealthEquity price target raised to $62 from $52 at Deutsche Bank
01/03/22 Barrington
Cars.com, Vizio among Barrington's 'Best Ideas' for 2002
12/08/21 Deutsche Bank
HealthEquity price target lowered to $52 from $75 at Deutsche Bank
12/07/21 Barrington
HealthEquity price target lowered to $55 from $80 at Barrington
PAGS PagSeguro Digital
$18.60 /

+1.56 (+9.15%)

02/18/22 Evercore ISI
StoneCo assumed with an In Line at Evercore ISI
02/18/22 Evercore ISI
PagSeguro Digital assumed with an In Line at Evercore ISI
02/01/22 Deutsche Bank
PagSeguro Digital price target lowered to $40 from $58 at Deutsche Bank
01/31/22 HSBC
PagSeguro Digital downgraded to Hold from Buy at HSBC
AIR AAR Corp.
$46.83 /

+0.79 (+1.72%)

01/27/22 RBC Capital
AAR Corp. price target raised to $50 from $45 at RBC Capital
10/21/21 RBC Capital
RBC starts AAR Corp. at Outperform with $45 price target
10/21/21 RBC Capital
AAR Corp. initiated with an Outperform at RBC Capital
07/21/21 Canaccord
AAR Corp. results reflect steady aero recovery, says Canaccord
LFG Archaea Energy
$19.55 /

-0.58 (-2.88%)

03/07/22 Stifel
Archaea Energy initiated with a Buy and placed on Select List at Stifel
01/18/22 Citi
Archaea Energy price target lowered to $29 from $31 at Citi
10/14/21 Johnson Rice
Archaea Energy initiated with a Buy at Johnson Rice
10/12/21 Citi
Archaea Energy initiated with a Buy at Citi
E Eni SpA
$28.86 /

+0.045 (+0.16%)

03/22/22 Morgan Stanley
Eni SpA downgraded to Equal Weight from Overweight at Morgan Stanley
03/21/22 RBC Capital
Eni SpA price target lowered to EUR 14 from EUR 15 at RBC Capital
03/21/22 JPMorgan
Eni SpA price target lowered to EUR 18.50 from EUR 19.50 at JPMorgan
03/21/22 HSBC
Eni SpA upgraded to Buy from Hold at HSBC
PLL Piedmont Lithium
$75.00 /

+ (+0.00%)

02/17/22 B. Riley
Piedmont Lithium price target raised to $95 from $89 at B. Riley
10/05/21 JPMorgan
Piedmont Lithium risks worth it given upside potential, says JPMorgan
10/04/21 Loop Capital
Piedmont Lithium price target raised to $108 from $86 at Loop Capital
07/23/21
Fly Intel: Top five analyst initiations
ZY Zymergen
$3.59 /

+0.275 (+8.30%)

XGN Exagen
$8.25 /

+0.21 (+2.61%)

WOR Worthington
$62.16 /

+0.92 (+1.50%)

SNPO Snap One
$20.48 /

+1.82 (+9.75%)

POSH Poshmark
$13.84 /

+1.305 (+10.41%)

PAYS Paysign
$2.50 /

+0.205 (+8.93%)

PAGS PagSeguro Digital
$18.60 /

+1.56 (+9.15%)

MXCT MaxCyte
$6.90 /

+0.24 (+3.60%)

LFG Archaea Energy
$19.55 /

-0.58 (-2.88%)

HQY HealthEquity
$58.53 /

+0.78 (+1.35%)

GAN Gan Limited
$5.45 /

-0.03 (-0.55%)

DNAY Codex DNA
$9.26 /

+0.425 (+4.81%)

AIR AAR Corp.
$46.83 /

+0.79 (+1.72%)

ADBE Adobe
$466.75 /

+13.36 (+2.95%)

ABSI Absci
$7.48 /

+0.415 (+5.88%)

  • 23
    Mar
  • 23
    Mar
  • 17
    Aug
  • 30
    Jul
  • 28
    Jul
  • 22
    Jul
  • 18
    Jun
  • 22
    Apr
  • 23
    Mar
  • 24
    Mar
PAGS PagSeguro Digital
$18.60 /

+1.56 (+9.15%)

GAN Gan Limited
$5.45 /

-0.03 (-0.55%)

ADBE Adobe
$466.75 /

+13.36 (+2.95%)

WOR Worthington
$62.16 /

+0.92 (+1.50%)

POSH Poshmark
$13.84 /

+1.305 (+10.41%)

PLL Piedmont Lithium
$75.00 /

+ (+0.00%)

PAGS PagSeguro Digital
$18.60 /

+1.56 (+9.15%)

HQY HealthEquity
$58.53 /

+0.78 (+1.35%)

GAN Gan Limited
$5.45 /

-0.03 (-0.55%)

DNAY Codex DNA
$9.26 /

+0.425 (+4.81%)

AIR AAR Corp.
$46.83 /

+0.79 (+1.72%)

ADBE Adobe
$466.75 /

+13.36 (+2.95%)

ABSI Absci
$7.48 /

+0.415 (+5.88%)

ZY Zymergen
$3.59 /

+0.275 (+8.30%)

SNPO Snap One
$20.48 /

+1.82 (+9.75%)

POSH Poshmark
$13.84 /

+1.305 (+10.41%)

PAGS PagSeguro Digital
$18.60 /

+1.56 (+9.15%)

MXCT MaxCyte
$6.90 /

+0.24 (+3.60%)

HQY HealthEquity
$58.53 /

+0.78 (+1.35%)

AIR AAR Corp.
$46.83 /

+0.79 (+1.72%)

ADBE Adobe
$466.75 /

+13.36 (+2.95%)

ABSI Absci
$7.48 /

+0.415 (+5.88%)

Earnings
Snap One sees FY22 revenue $1.14B-$1.17B, consensus $1.1B » 16:23
03/22/22
03/22
16:23
03/22/22
16:23
SNPO

Snap One

$20.48 /

+1.82 (+9.75%)

"Demand for our…

"Demand for our products and services remains high as we enter 2022," Heyman continued. "Despite supply chain uncertainty, we have strong conviction in both the short and long-term growth outlook for our business. We expect net sales in the fiscal year ending December 30, 2022, to range between $1.14B and $1.17B, which would represent an increase of 13% to 16% compared to the prior fiscal year on an as reported basis, and 15% to 18% after adjusting fiscal 2021 to remove the impact of a 53rd week."For fiscal 2022, we expect adjusted EBITDA to range between $114M and $120M, which would represent an increase of 3% to 8% compared to the prior fiscal year on an as reported basis. Presenting 2021 on a 52-week adjusted basis and normalizing for a full year of public company costs, our 2022 adjusted EBITDA guidance would represent a year over year increase of 8% to 14%. Our adjusted EBITDA guidance considers long-term growth investments as well as ongoing supply chain cost pressures partially offset by our historical pricing actions. "We enter 2022 in a robust demand environment and continue to take a leadership position in growing the industry. We are focused on delivering strong growth and margin expansion over the long-term, while also reinvesting in the success of Snap One and revolutionizing smart living."

ShowHide Related Items >><<
SNPO Snap One
$20.48 /

+1.82 (+9.75%)

SNPO Snap One
$20.48 /

+1.82 (+9.75%)

12/09/21 Morgan Stanley
Snap One downgraded to Equal Weight at Morgan Stanley following 'too fast' rally
12/09/21 Morgan Stanley
Snap One downgraded to Equal Weight from Overweight at Morgan Stanley
09/30/21 Imperial Capital
Snap One initiated with an Outperform at Imperial Capital
08/23/21 UBS
Snap One initiated with a Buy at UBS
SNPO Snap One
$20.48 /

+1.82 (+9.75%)

  • 28
    Jul
SNPO Snap One
$20.48 /

+1.82 (+9.75%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.